Structures by: Gök Y.
Total: 6
1,3-Bis(4-methylbenzyl)-1<i>H</i>-1,3-benzimidazol-3-ium bromide monohydrate
C23H23N2,Br,H2O
Acta Crystallographica Section E (2015) 71, 1 o10-o11
a=9.3846(3)Å b=9.7174(3)Å c=12.5603(4)Å
α=76.405(2)° β=84.739(2)° γ=72.696(2)°
1,3-Bis[(5-aminofuran-2-yl)methyl]-3,4,5,6-tetrahydropyrimidin-1-ium hexafluorophosphate
C16H21N2O2,F6P
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1325
a=6.0793(6)Å b=18.879(2)Å c=8.5750(9)Å
α=90° β=100.747(5)° γ=90°
1,3-Bis[4-(dimethylamino)benzyl]-4,5,6,7-tetrahydro-1<i>H</i>-1,3-diazepan-2-ium chloride
C23H33N4,Cl
Acta Crystallographica Section E (2009) 65, 1 o109-o110
a=22.663(5)Å b=10.081(2)Å c=9.6368(19)Å
α=90.0° β=90.0° γ=90.0°
1,3-Bis(thiophen-2-ylmethyl)-3,4,5,6-tetrahydropyrimidinium trichlorido(η^6^-<i>p</i>-cymene)ruthenate(II)
C14H17N2S2,C10H14Cl3Ru
Acta Crystallographica Section E (2009) 65, 1 m111-m112
a=9.989(2)Å b=11.404(2)Å c=12.922(3)Å
α=82.10(3)° β=67.61(3)° γ=72.59(3)°
1,3-Bis(2-thienylmethyl)-4,5-dihydroimidazolium trichlorido(η^6^-<i>p</i>-cymene)ruthenate(II)
C13H15N2S2,C10H14Cl3Ru
Acta Crystallographica Section E (2009) 65, 2 m165-m166
a=9.910(2)Å b=11.600(2)Å c=12.659(3)Å
α=84.95(3)° β=67.05(3)° γ=74.14(3)°
Chlorido[1-phenyl-3-(2,3,5,6-tetramethylbenzyl)benzimidazol-2-ylidene]silver(I)
C24H24AgClN2
Acta Crystallographica Section E (2012) 68, 5 m590-m591
a=9.1439(2)Å b=18.7633(4)Å c=13.2710(3)Å
α=90° β=109.8990(10)° γ=90°